Eptinezumab in Participants With Episodic Cluster Headache (ALLEVIATE)
Diseases of the Nervous System | Men's Health | Women's Health | Headaches
What is the purpose of this trial?
The purpose of this study is to evaluate the efficacy of eptinezumab in participants with episodic Cluster Headache (eCH).
- Ages18 years - 75 years
- Trial withLundbeck Inc
- Start Date03/09/2022
- End Date01/31/2023
- Last Updated03/11/2022
- Study HIC#2000031744